AlphAIAlphAI — Financial news for AI agents
fool.com$IEX

IDEX (IEX) Q3 2026 Earnings Call Transcript

IDEX (IEX) reported Q3 2026 net sales of $952M, up 8%, and adjusted EPS of $2.33, up 15%. Organic orders reached $991M, growing 13%. HST, FMT, and FSDP segments showed growth. Full-year guidance raised: organic growth 6.5-6.8%, adjusted EPS $8.91-$8.96. Inflation and chemical sector weakness noted as risks.

Original reporting
fool.com
Published Oct 28, 2026, 5:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 6:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
IDEX (IEX) Q3 2026 Earnings Call Transcript — source image
Source · fool.com
Decision brief

The 30-second read

$IEXBullishHigh
01

Why it matters

The earnings beat and guidance raise expectations for continued growth in AI, data‑center, and semiconductor markets, supporting a bullish stance on the stock.

02

Market read

First‑report earnings data for IDEX, a mid‑cap industrial tech company, with material guidance uplift.

03

What to watch

Potential headwinds from inflationary pressure on input costs and chemical market fatigue.

Relevance 8/10Novelty 8/10Timing: post-earnings release today

Background

IDEX Corp (IEX) released its Q3 2026 earnings call transcript, highlighting record sales, EPS beat, and raised full‑year guidance.

Company-level read

Ticker impact

$IEXBullishHigh confidence
Context

IDEX Corp reported record Q3 sales of $952M, adjusted EPS $2.33 and raised FY2026 guidance, a fresh earnings disclosure.

Expected impact

likely upward pressure as investors price in higher guidance and record results

Evidence & confidence

Record sales, EPS beat, and upgraded FY2026 guidance provide clear catalyst for price appreciation.

Market effects

Sector

Boosts outlook for industrial automation and high‑tech components sectors.

Regional

Positive for US industrial equities, especially mid‑cap manufacturers.

Global

Limited to investors tracking US industrial and technology exposure.

Counterpoint

What could challenge this read

Some analysts may question margin sustainability given rising input costs.

Key entities

  • Executive
    Eric D. Ashleman

    President and CEO of IDEX, provided earnings commentary.

  • Executive
    Sean Gillen

    Chief Financial Officer, discussed financial details and outlook.

Read at source← All news

StoryIDEX beats third-quarter expectations and raises 2026 outlook

Also covered by

3 outlets

Related articles

$IEXHighAI 8/10

DA Davidson raises IDEX stock price target to $245 on strength

DA Davidson raised its price target on IDEX Corp (NYSE:IEX) to $245 from $240, citing strength in its Health & Science Technologies and Fire & Safety segments. The stock has risen 39% over the past year. IDEX reported Q3 2026 earnings of $2.33 per share, beating estimates, with revenue of $952 million. The company also raised its full-year guidance.

investing.com
$IEXMedAI 8/10

Idex: Q3 Earnings Snapshot

IDEX Corp. (IEX) reported Q3 net income of $144.1M, or $1.95 per share, exceeding analyst estimates. Adjusted EPS was $2.33. Revenue was $951.7M, also beating forecasts. The company raised its full-year EPS guidance to $8.91-$8.96 per share.

finance.yahoo.com
$IEXHighAI 8/10

IDEX Q3 2026 slides: advantaged markets drive beat, guidance raised

IDEX Corporation (NYSE:IEX) reported Q3 2026 earnings with 8% organic sales growth and 15% increase in adjusted EPS, driven by 'advantaged markets'. Sales reached $952M, adjusted EBITDA margin expanded to 27.8%, and free cash flow grew 14%. The company raised its full-year outlook, with shares up 0.92% to $235.35. HST segment led growth with 13% organic sales growth.

investing.com
$IEXMedAI 8/10

IDEX (NYSE:IEX) beats Q3 2026 sales expectations

IDEX reported Q3 2026 revenue of $951.7 million, beating estimates by 1.8%. Adjusted EPS was $2.33, a 4% beat. Adjusted EBITDA reached $264.8 million, a 3.2% beat. Management raised full-year adjusted EPS guidance to $8.94. Operating margin remained steady at 21.9%, while free cash flow margin improved to 22.5%.

finance.yahoo.com
$IEXHighAI 9/10

IDEX beats estimates and lifts guidance as orders surge

IDEX Corporation (NYSE:IEX) reported Q3 earnings of $2.33 per share, beating estimates by $0.09, with revenue of $952M, up 8% YoY. Orders rose 13% to $991M. The company raised full-year EPS guidance to $8.91-$8.96 and increased organic sales growth outlook to 6.5%-6.8%. Shares rose 2.4% post-announcement. Growth was driven by AI and semiconductor demand, particularly in the Health & Science Technologies segment.

investing.com